The effect of polymeric nanoparticles on biocompatibility of carrier red blood cells

PLoS ONE

Volumn 11, Issue 3, 2016, Pages

  Pan, Daniel ^a   Vargas Morales, Omayra ^a   Zern, Blaine ^a   Anselmo, Aaron C ^b   Gupta, Vivek ^b   Zakrewsky, Michael ^b   Mitragotri, Samir ^b   Muzykantov, Vladimir ^a  

^a University of Pennsylvania   (United States)

^b University of California   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BUFFER; DRUG CARRIER; NANOPARTICLE; ALBUMINOID; BIOMATERIAL; POLYMER;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; CELL DAMAGE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENCAPSULATION; ERYTHROCYTE; HEMAGGLUTINATION; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG BLOOD VESSEL; MALE; MECHANICAL STRESS; MOUSE; NONHUMAN; OSMOTIC STRESS; OXIDATIVE STRESS; PARTICLE SIZE; ANIMAL; CHEMISTRY; ERYTHROCYTE COUNT; METABOLISM; PROCEDURES; SENSITIVITY AND SPECIFICITY;

ALBUMINS; ANIMALS; BIOCOMPATIBLE MATERIALS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; ERYTHROCYTE COUNT; ERYTHROCYTES; MALE; MICE; NANOPARTICLES; POLYMERS; SENSITIVITY AND SPECIFICITY;

EID: 84962191007     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0152074     Document Type: Article

References (62)

1. Rossi L, Serafini S, Pierige F, Antonelli A, Cerasi A, Fraternale A, et al. Erythrocyte-based Drug Delivery. Expert Opin on Drug Delivery. 2005; 2(2): 311-322.
2. Muzykantov V. (2010). Drug Delivery by Red Blood Cells: Vascular Carriers Designed by Mother Nature. Expert Opin on Drug Delivery. 2010; 7(4): 403-427.
3. Anselmo A, Gupta V, Zern B, Pan D, Zakrewsky M, Muzykantov V, et al. Delivering nanoparticles to lung while avoiding liver and spleen through adsorption on red blood cells. ACS Nano. 2013; 7(12): 1129-1137.
4. Anselmo A and Mitragotri S. Cell-mediated delivery of nanoparticles. Taking advantage of circulatory to target nanoparticles. J Control Release. 2014; 190: 531-541. doi:10.1016/j.jconrel.2014.03.050 PMID: 24747161.
5. Murciano J, Medinilla S, Eslin D, Atochina E, Cines D, and Muzykantov V. Prophylactic fibrinolysis through selective dissolution of nascent colts by tPA-carrying erythrocyte. Nat Biotechnol. 2003; 21(8): 891-896. PMID: 12845330.
6. Zaitsev S, Danielyan K, Murciano J, Ganguly K, Krasik T, Taylor R, Pincus S, Jones S, Cines D, and Muzykantov V. Human complement receptor type 1-directed loading of tissue plasminogen activator on circulating erythrocytes for prophylactic fibrinolysis. Blood. 2006; 108(6): 1895-1902. PMID: 16735601.
7. Zaitsev S, Spitzer D, Murciano J, Ding B, Tliba S, Kowalska M, et al. Targeting of a mutant plasminogen activator to circulating red blood cells for prophylactic fibrinolysis. J Pharmacol Exp Ther. 2010; 332(3): 1022-1031. doi:10.1124/jpet.109.159194 PMID: 19952305.
8. Zaitsev S, Spitzer D, Murciano J, Ding B, Tliba S, Kowlaska M, et al. Sustained thrombophrophylaxis mediated by an RBC-targeted pro-urokinase zymogren activated at the site of clot formation. Blood. 2010; 115(25): 5241-4248. doi:10.1182/blood-2010-01-261610 PMID: 20410503.
9. Zaitsev S, Kowalska M, Neyman M, Carnemolla R, Tliba S, Ding B. et al. Targeting recombinant thrombomodulin fusion proteins to red blood cells provides multifaceted thromboprophylaxis. Blood. 2012; 119(20): 4779-4785. doi:10.1182/blood-2011-12-398149 PMID: 22493296.
10. Danielyan K, Ganguly K, Ding B, Atochin D, Zaitsev S, Muricano J, et al. Cerebrovascular thromboprophylaxis in mice by erythrocyte-coupled tissue-type plasminogen activator. Circulation. 2008; 118(14): 1442-1449. doi:10.1161/CIRCULATIONAHA.107.750257 PMID: 18794394.
11. Gersh K, Zaitsev S, Cines D, Muzykantov, and Weisel J. Flow-dependent channel formation in clots by an erythrocyte-bound fibrinolytic agent. Blood. 2011; 117(18): 4964-4967. doi:10.1182/blood-2010-10-310409 PMID: 21389322.
12. Koshkaryev A, Sawant R, Deshpande M and Torchilin V. Immunoconjugates and long circulating systems: origins current state of art and future directions. Advanced Drug Delivery Reviews. 2013; 65(1): 24-35. doi:10.1016/j.addr.2012.08.009 PMID: 22964425.
13. Chambers E and Mitragotri S. Long circulating nanoparticles via adhesion on red blood cells: mechanism and extended circulation. Exp Bio Med. 2007; 233(7): 958-966.
14. Anselmo AC, Kumar S, Gupta V, Pearce AM, Ragusa A, Muzykantov V, et al. Exploiting shape, cellular- hitchhiking and antibodies to target nanoparticles to lung endothelium: Synergy between physical, chemical, and biological approaches. Biomaterials. 2015; 68:1-8. doi:10.1016/j.biomaterials.2015.07.043 PMID: 26241497.
15. Chen LQ, Fang L, Ling J, Ding CZ, Kang B, and Huang CZ. Nanotoxicity of Silver Nanoparticles to Red Blood Cells: Size Dependent Adsorption, Uptake, and Hemolytic Activity. Chem Res Toxicol. 2015; 28 (3): 501-509. doi:10.1021/tx500479m PMID: 25602487.
16. Zhao Y, Sun X, Zhang G, Trewyn BG, Slowing II, and Lin VSY. Interaction of Mesoporous Silica Nanoparticles with Human Red Blood Cell Membranes: Size and Surface Effects. ACS Nano. 2011; 5(2): 1366-1375. doi:10.1021/nn103077k PMID: 21294526.
17. Muzykantov V, Samokhin G, Smirnov M, and Domogatsky S. Hemolytic complement activity assay in microtitration plates. J. Appl. Biochem. 1985; 7(3): 223-227. PMID: 3902766.
18. Muzykantov V, Smirnov M, and Samokhin G. Avidin acylation prevents the complement-dependent lysis of avidin-carrying erythrocytes. Biochem J. 1991; 273(Part 2): 393-397.
19. Muzykantov V, Smirnov M, and Samokhin G. Strepavidin-induced lysis of homologous biotinylated erythrocytes. Evidence against the key role of the avidin charge in complement activation via the alternative pathway. FEBS Letters. 1991; 280(1): 112-114. PMID: 2009954.
20. Muzykantov V, Smirnov M, and Klibanov A. Avidin attachment to biotinylated amino groups of the erythrocyte membrane eliminates homologous restriction of both classical and alternative pathways of the complement. FEBS Letters. 1993; 318(2): 1065-1069.
21. Kuypers F. Red cell membrane damage J Heart Valve Dis. 1998; 7(4): 387-395. PMID: 9697059.
22. Yen J, Chen S, Chern M, and Lu P. The effect of turbulent viscous shear stress on red blood cell hemolysis. J Artif Organs. 2014; 17(2): 178-185. doi:10.1007/s10047-014-0755-3 PMID: 24619800.
23. Sallam A and Hwang N. Human red blood cell hemolysis in a turburent shear flow: contribution of Reynolds shear stress. Biorheology. 1984; 21(6): 783-797. PMID: 6240286.
24. Down L, Papavassiliou D, and O'Hear E. Significance of extensional stresses to red blood cell lysis in a shearing low. Ann Biomed Eng. 2011; 39(6): 1632-1642. doi:10.1007/s10439-011-0262-0 PMID: 21298343.
25. Muzykantov V, Seregina N, Smirnov M. Fast lysis by complement and uptake by liver of avidin-carrying biotinylated erythrocytes. Int J Artif Organs. 1992; 15(10): 622-627. PMID: 1428212.
26. Muzykantov V, Smirnov M, and Samokhin G. Avidin-induced lysis of biotinylated erythrocytes by homologous complement via the alternative pathway depends on avidin's ability of multipoint binding with biotinylated membrane. Biochim Biophys Acta. 1992; 1107(1): 119-125. PMID: 1616915.
27. Muzykantov V, Smirnov M, and Klibanov A. Avidin attachment to red blood cells via a phospholipid derivative of biotin provides complement-resistant immunoerythrocytes. J Immuno Methods. 1993; 158(2): 183-190.
28. Muzykantov V and Murciano J. Attachment of antibody to biotinylated red blood cells: immuno-red blood cells display high affinity to immobilized antigen and normal biodistribution in rats. Biotechnol Appl Biochem. 1996; 24(Part 1): 41-45.
29. Muzykantov V, Murciano J, Taylor R, Atochina E, and Herraez A. Regulation of the complement-mediated elimination of red blood cells modified with biotin and streptavidin. Anal Biochem. 1996; 241(1): 109-119. PMID: 8921172.
30. Evans BC, Nelson CE, Yu SS, Beavers KR, Kim AJ, Li H, et al. Ex Vivo Red Blood Cell Hemolysis Assay for the Evaluation of pH-responsive Endosomolytic Agents for Cytosolic Delivery of Biomacromolecular Drugs. J Vis Exp. 2013; 73: e50166. doi:10.3791/50166 PMID: 23524982.
31. Villa CH, Pan DC, Zaitsev S, Cines DB, Siegel DL, and Muzykantov VR. Delivery of drugs bound to erythrocytes: new avenues for an old intravascular carrier. Ther Deliv. 2015; 6(7): 795-826. doi:10.4155/tde.15.34 PMID: 26228773.
32. Brazile D, Prud'homme C, Bassoulett M, Marland M, Spenlehauer G, and Veillard M. Stealth Me. PEGPLA nanoparticles avoid uptake by the mononuclear phagocytes system. J. Pharm Sci. 1996; 84(4): 493-498.
33. Perry J, Reuter K, Kai M, Herlihy K, Jones W, Luft C, et al. Napier M, Bear J, and DeSimone J. PEGylated PRINT nanoparticles: The impact of PEG density on protein binding, macrophage association, biodistribution and pharmacokinetics. Nano Lett. 2012; 12(10): 5304-5310. doi:10.1021/nl302638g PMID: 22920324.
34. Serafini S, Rossi L, Antonelli A, Fraternale A, Cerasi A, Crinelli R, et al. Drug Delivery through Phagocytosis of Red Blood Cells. Transfus Med Hemother. 2004; 31(2): 92-101.
35. Godfrin Y, Horand F, Franco R, Dufour E, Kosenko E, Bax B, et al. (2012). International seminar on the red blood cells as vehicles for drugs. Expert Opin Bio Ther. 2012; 12(1): 127-133.
36. Cremel M, Guerin N, Horand F, Banz A, and Godfrin Y. Red blood cells as innovative antigen carrier to induce specific immune tolerance. Int J. Pharm. 2013; 443(1-2): 39-49. doi:10.1016/j.ijpharm.2012.12.044 PMID: 23305866.
37. Mukthavaram R, Shi G, Kersari S, and Simberg D. Targeting and depletion of circulating leukocytes and cancer cells by lipophilic antibody-modified erythrocytes. J Control Release 2014; 183: 146-153. doi:10.1016/j.jconrel.2014.03.038 PMID: 24685706.
38. Atukorale P, Yang YS, Bekdemir A, Carney R, Silva P, Watson N, et al. Influence of the Glycocalyx and Plasma Membrane Composition on Amphiphilic Cold Nanoparticles Associated with Erythrocytes. Nanoscale. 2015; 7: 11420-11432. doi:10.1039/c5nr01355k PMID: 26077112.
39. Becker P, Cohen C, and Lux S. (1986). The effect of mild diamide oxidation on the structure and function of human erythrocytes spectrin. J. Bio Chem. 1986; 261(10): 4620-4628.
40. Clemens R and Waller H. Lipid peroxidation in erythrocytes. Chem. Phys. Lipids. 1987; 45(2-4): 251- 268. PMID: 3319229.
41. Wagner G, Chiu D, Qui H, Heath R, and Lubin B. Spectrin oxidation correlates with membrane vesiculation in stored RBCs. Blood. 1987; 69(6):1771-1781. PMID: 3580578.
42. Hebbel R, Leung A, and Mohandas N. Oxidation-induced changes in microrheologic properties of the red blood cell membrane. Blood. 1990; 76(5): 1015-1020. PMID: 2393710.
43. Bartosz G.Erythrocyte aging: physical and chemical membrane changes: Gerontology. 1991; 37(1-3): 33-67. PMID: 2055498.
44. Waugh E, Narla M, Jackson C, Mueller T, Suzuki T, and Dale G. (Rheologic properties of senescent erythrocytes: loss of surface area and volume with red blood cell age: Blood. 1992; 79(5): 1351-1358. PMID: 1536958.
45. Gutteridge J. Lipid peroxidation and antioxidants as biomarkers for tissue damage. Clin Chem. 1995; 41(12 part 2): 1819:1828. PMID: 7497639.
46. Nagabagu E, Gulyani S, Earley C, Culter R, Mattson M, and Rifkind J. Iron-deficiency anemia enhances red blood cell oxidative stress. Free Radic. Res. 2008; 42(9): 824-829. doi:10.1080/10715760802459879PMID: 19051108.
47. Barodka V, Nagababu E, Mohanty J, Nyhan D, Berkowitz D, Rifkind J, et al. New insights provided by a comparsion of impaired deformability with erythrocyte oxidative stress for sickle cell disease. Blood Cells Mol Dis. 2014; 52(4): 230-235. doi:10.1016/j.bcmd.2013.10.004 PMID: 24246527.
48. Mandal D, Baudin-Creuza V, Bhattacharyya A, Pathak S, Delaunay J, Kundu M, et al. Caspase 3-mediated proteolysis of the N-terminal cytoplasmic domain of the human erythroid anion exchange 1 (band 3). J. Biol. Chem. 2003; 278(52): 52551-52558. PMID: 14570914.
49. Grey J, Kodippili G, Simon K, and Low P. Identification of contact sites between ankyrin and band 3 in the human erythrocyte membrane. Biochemistry. 2012; 51(34): 6838-6846. PMID: 22861190.
50. Gonzalez R, Auclair C, Voisin E, Gautero H, Dhermy D, and Boivin P. Superoxide dismutase, catalase, and glutathione peroxidase in red blood cells from patients with malignant disease. Cancer Res. 1984; 44(9): 4137-4139. PMID: 6589047.
51. Muzykantov V, Sakharov D, Domogatsky S, Goncharov N, and Danilov S. Directed targeting of immunoerythrocytes provides local protection of endothelial cells from damage by hydrogen peroxide. Am J Pathol. 1987; 128(2): 276-285. PMID: 3618728.
52. Nagababu E, Monhanty J, Bhamidipaty S, Ostera G, and Rifkind J. Role of the membrane in the formation of heme degradation products in red blood cells. Life Sci. 2010; 86(3-4): 133-138. doi:10.1016/j.lfs.2009.11.015 PMID: 19958781.
53. Lee T, Kim S, Yu S, Kim S, Park D, Moon H, et al. Peroxiredoxin II is essential for sustaining life span of erythrocytes in mice. Blood. 2003; 101(12): 5033-5038. PMID: 12586629.
54. Nagababu E, Mohanty J, Friedman J, Rifkind J. Role of peroxiredoxin-2 in protecting RBCs from hydrogen peroxide-induced oxidative stress. Free Radic. Res. 2013; 47(3): 164-171. doi:10.3109/10715762.2012.756138 PMID: 23215741.
55. Scott M, Murad K, Koumpouras F, Talbot M, and Eaton J. Chemical camouflage of antigenic determinants: "Stealth" erythrocytes. Proc Natl Acad Sci USA. 1997; 94(14): 7566-7571. PMID: 9207132.
56. Murad K, Mahany K, Brugnara C, Kuypers F, Eaton J, and Scott M. Structural and functional consequences of antigenic modulation of red blood cells with methoxypoly(ethylene glycol). Blood. 1999; 93 (6): 2121-2127. PMID: 10068687.
57. Scott M, Murad K, Koumporouras K, Talbot M, and Eaton J. Chemical camouflage of antigenic determinants. Stealth erythrocytes. Proc Natl Acad Sci USA. 1997; 94(14): 7566-7571. PMID: 9207132.
58. Liu Z, Janzen J, and Brooks D. Adsorption of amphilphilic hyperbranched polyglycerol derivates onto red blood cells. Biomaterials. 2010; 31(12): 3364-3373. doi:10.1016/j.biomaterials.2010.01.021PMID: 20122720.
59. Lin J, Hua W, Zhang Y, Li C, Xue W, Yin J, et al. Effect of poly(amidoamine) dendrimers on the structure and activity of immune molecule. Biochim Biophys Acta. 2015; 1850(2): 419-425. doi:10.1016/j.bbagen.2014.11.016 PMID: 25463324.
60. Li C, Jin J, Liu J, Xu X, and Yin J. Stimuli-Responsive Polypropylene for the Sustained Delivery of TPGS and Interactions with Erythrocytes. ACS Appl Mater Interfaces. 2014; 6(16): 13956-13967. doi:10.1021/am503332z PMID: 25051204.
61. Gundersen S, and Palmer A. Conjugation of Methoxpolyethylene Glycol to the Surface of Bovine Red Blood Cells. Biotechnol Bioeng. 2007; 96(6): 1199-1210. PMID: 17009332.
62. Kontos S, Kourtis I, Dane K, and Hubbell J. Engineering antigens for in site erythrocytes binding induces T-cell deletions. Proc Natl Acad Sci USA. 2013; 110(1): E60-E68. doi:10.1073/pnas.1216353110PMID: 23248266.